Condition

Fallopian Tube Carcinoma

ClinicalTrials.gov condition label

Clinical trials11
Recruiting3
Common interventions25
Lead sponsors shown7

Clinical trials

11 shown
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044 · 2025-12-18
RECRUITING
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationNCT05059444 · 2021-09-07
RECRUITING
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFNCT03604315 · 2018-12-18
RECRUITING
NM32-2668 in Adult Patients With Selected Advanced Solid TumorsNCT06299163 · 2024-05-01
TERMINATED
National Cancer Institute "Cancer Moonshot Biobank"NCT04314401 · 2020-11-11
ACTIVE_NOT_RECRUITING
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesNCT04257045 · 2019-08-21
COMPLETED
A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsNCT03517488 · 2018-07-10
COMPLETED
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesNCT02419495 · 2015-06-26
TERMINATED
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199NCT01445275 · 2011-01-01
WITHDRAWN
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian CancerNCT01139957 · 2010-06-07
COMPLETED
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerNCT01116648 · 2010-04-14
ACTIVE_NOT_RECRUITING

Common interventions

Computed TomographyPROCEDURE3Questionnaire AdministrationOTHER3Biospecimen CollectionPROCEDURE2Evaluation of Cancer Risk FactorsPROCEDURE2Magnetic Resonance ImagingPROCEDURE2Medical Chart ReviewOTHER2OlaparibDRUG2Positron Emission TomographyPROCEDURE2Biopsy ProcedurePROCEDURE1Cancer Therapeutic ProcedureDRUG1CapecitabineDRUG1CarboplatinDRUG1Cediranib MaleateDRUG1CyclophosphamideDRUG1DoxorubicinDRUG1Echocardiography TestPROCEDURE1EribulinDRUG1Fludeoxyglucose F-18RADIATION1Fluorine F 18 FluorthanatraceRADIATION1FluorouracilDRUG1Guardant RevealDIAGNOSTIC_TEST1InterviewOTHER1IpilimumabBIOLOGICAL1Irinotecan HydrochlorideDRUG1Leucovorin CalciumDRUG1

Trial status mix

COMPLETED3
RECRUITING3
ACTIVE_NOT_RECRUITING2
TERMINATED2
WITHDRAWN1

Phase mix

PHASE15
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.